Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: J Trauma Acute Care Surg. 2024 Jan 8;96(5):715–726. doi: 10.1097/TA.0000000000004248

Improving Outcomes in EGS: Construct of a Collaborative Quality Initiative

Mark R Hemmila 1,2, Pooja U Neiman 2,3,4, Beckie L Hoppe 1, Laura Gerhardinger 1,2, Kim A Kramer 1, Jill L Jakubus 1, Judy N Mikhail 1, Amanda Y Yang 5, Hugh J Lindsey 6, Roy J Golden 7, Eric J Mitchell 8, John W Scott 1,2, Lena M Napolitano 1
PMCID: PMC11042990  NIHMSID: NIHMS1951924  PMID: 38189669

Abstract

Background:

Emergency general surgery conditions are common, costly, and highly morbid. The proportion of excess morbidity due to variation in health systems and processes of care is poorly understood. We constructed a collaborative quality initiative for emergency general surgery to investigate the emergency general surgery care provided and guide process improvements.

Methods:

We collected data at ten hospitals from 7/2019-12/2022. Five cohorts were defined: acute appendicitis, acute gallbladder disease, small bowel obstruction, emergency laparotomy, and overall aggregate. Processes and inpatient outcomes investigated included operative vs. non-operative management, mortality, morbidity (mortality and/or complication), readmissions, and length of stay. Multivariable risk adjustment accounted for variations in demographic, comorbid, anatomic, and disease traits.

Results:

Of the 19,956 emergency general surgery patients, 56.8% were female and 82.8% were white, and the mean (SD) age was 53.3 (20.8) years. After accounting for patient and disease factors, the adjusted aggregate mortality rate was 3.5% (95% CI, 3.2–3.7), morbidity 27.6% (95% CI, 27.0–28.3), and the readmission rate was 15.1% (95% CI, 14.6–15.6). Operative management varied between hospitals from 70.9% to 96.9% for acute appendicitis and 19.8% to 79.4% for small bowel obstruction. Significant differences in outcomes between hospitals were observed with high- and low-outlier performers identified after risk adjustment in the overall cohort for mortality, morbidity, and readmissions. The use of a Gastrografin challenge in patients with a small bowel obstruction ranged from 10.7% to 61.4% of patients. In patients who underwent initial non-operative management of acute cholecystitis, 51.5% had a cholecystostomy tube placed. The cholecystostomy tube placement rate ranged from 23.5% to 62.1% across hospitals.

Conclusions:

A multihospital emergency general surgery collaborative reveals high morbidity with substantial variability in processes and outcomes among hospitals. A targeted collaborative quality improvement effort can identify outliers in emergency general surgery care and may provide a mechanism to optimize outcomes.

Level of Evidence:

III, therapeutic/care management

Keywords: Emergency general surgery, collaborative quality improvement, process measures

Social Media:

Media summary: Emergency general surgery outcomes and processes can be measured in a collaborative quality initiative setting. This work from @UMichSurgery provides a framework to monitor and improve outcomes for patients with EGS conditions. Read more in @JTraumAcuteSurg

Hashtags: #egs, #emergencysurgery, #surgicalquality

Social media handles:

• University of Michigan Department of Surgery- @UMichSurgery

• University of Michigan Division of Acute Care Surgery - @UMichACS

• Institute for Healthcare Policy and Innovation - @UM_IHPI

• John W. Scott - @DrJohnScott

Background

The specialty of acute care surgery originated in response to a need for a surgical provider workforce with expertise in trauma care, emergency general surgery, and surgical critical care.13 Twenty percent of inpatient acute care admissions are for traumatic injury or one of 16 emergency general surgery diseases.4 This trauma and emergency general surgery disease cohort accounts for $86 billion or 25% of United States inpatient health care spending out of $341 billion annually.4 Hospital admissions for emergency general surgery have steadily increased over the past 20 years and are projected to continue to grow.5 Emergency general surgery operations carry a 30–40% increased risk of mortality or morbidity compared to similar general surgery operations in the non-emergent setting after accounting for patient and procedure-associated risk factors.6

Because emergency general surgery is prevalent, is associated with substantial healthcare expenditures, and has a considerable rate of adverse outcomes, it represents a potential high-yield environment for quality improvement efforts. In fact, emergency general surgery patients cared for at hospitals with lower risk-adjusted trauma mortality have an approximate 33% reduction in mortality risk.7 The construct of a high-performing quality improvement effort relies on many factors. The following four principles have been suggested to build a quality improvement endeavor in emergency general surgery:8

  1. Standardization of emergency general surgery definitions;

  2. Ability to conduct an emergency general surgery severity assessment (clinical, anatomic, and imaging) for risk-adjustment of outcomes;

  3. Creation of an emergency general surgery data registry, which includes operative and nonoperative management; and

  4. Standardization of emergency general surgery patient care using evidence-based guidelines and bundles.

To address the need for quality improvement in emergency general surgery, we have created an emergency general surgery collaborative centered on these four principles. Based on prior work in regional trauma quality improvement, we propose that inclusion of a collaborative quality initiative (CQI) environment is necessary to optimize the quality improvement infrastructure in addition to following the four principles listed.9 Here, we describe the construct and initial results from an emergency general surgery CQI.

Methods

A total of 16 different disease states have been identified to potentially examine emergency general surgery outcomes.10 Unfortunately, attempting to collect data on all of these disease states at once resembles an attempt “to drink the ocean.” However, seven operative procedures (laparotomy, peptic ulcer disease repair, small bowel resection, partial colectomy, lysis of adhesions, cholecystectomy, and appendectomy) account for most operations (80%), deaths (80%), complications (79%), and inpatient costs (80%) attributable to emergency general surgery in the United States per year.11 Given these facts, we focused our emergency general surgery collaborative on four clinical domains: acute appendicitis, acute gallbladder disease, small bowel obstruction, and emergent exploratory laparotomy.

Hospital participants for the Michigan Acute Care Surgery (MACS) CQI were recruited from existing Michigan Trauma Quality Improvement Program (MTQIP) enrolled trauma centers. We began with four hospitals in July 2019 and currently have 10 participant hospitals. Participation is voluntary, and each hospital receives 85% salary and benefits funding from Blue Cross Blue Shield of Michigan/Blue Care Network for a 1.0 full-time equivalent (FTE) data abstractor. Each hospital is responsible for funding the remaining 15% of the position. Future data abstractor reimbursement will depend on patient volume with a base metric of 85% funding of 1.0 FTE for 750 cases. The eligibility and expectations for MACS enrollment and participation are detailed in a document provided to all participant hospitals prior to MACS enrollment (SDC 1).

Data Collection and Data Definitions

The objective is to screen the daily Acute Care Surgical service “touches” at each MACS hospital to identify patients who meet the criteria for further data entry (Figure 1). Patients were identified from the initial census records (e.g., consults, admissions, and operative cases). Final data capture was completed after discharge from the hospital. The specific patient diseases or conditions captured for emergency general surgery are the following:

  1. Acute Appendicitis

  2. Acute Gallbladder Disease
    1. Acute Cholecystitis
    2. Choledocholithiasis
    3. Cholangitis
    4. Gallstone Pancreatitis
  3. Small Bowel Obstruction
    1. Adhesive
    2. Hernia
    3. Malignancy/Mass/Stricture/Other
  4. Emergent Exploratory Laparotomy (including laparoscopic approach)

Figure 1.

Figure 1.

Flowchart describing data capture of emergency department visits and admission episodes for new and existing emergency general surgery patients.

The ICD-10-CM codes and algorithms utilized for MACS inclusion and exclusion criteria are available in a patient selection document (SDC 2). After the daily census for patients admitted to the Acute Care Surgery Service or seen as a consult is screened, other electronic medical record (EMR) and information technology sources may be utilized for additional patient selection screening. Beyond the recommendations in the patient selection document, each hospital was free to utilize additional individualized methods for identifying potential patients based upon institution-specific features that may be present. Patients who underwent emergent operative intervention for small bowel obstruction due to a hernia, internal hernia, volvulus, or mass/malignancy etiology were included in the emergent exploratory laparotomy cohort (SDC 3). Patients assigned to the small bowel obstruction cohort received either no operative intervention, an urgent or planned operation after admission, or an emergent operation for obstruction due purely to adhesions.

The first level of data entry, after inclusion and exclusion criteria screening, involves the entry of the patient into the MACS database. This database is constructed using software from the Qualtrics XM Platform. All adult patients (age ≥ 18 years) with the identified disease or condition have data entered regardless of whether they received an operation during admission or emergency department (ED) visit. The second level of data entry occurs if an existing MACS patient returns to the hospital (ED visit or admission) or has outcome events identified within the 30-day post-operative time frame if the patient had surgery or within 30-days from discharge for the nonoperative patients. Data collection did not involve contacting patients and only utilized information that was part of the treating institutions medical record system. In addition to demographic, comorbid conditions, and outcomes data, information is captured on diagnostic and therapeutic interventions (e.g., endoscopic retrograde cholangiopancreatography), including radiologic studies, interventional procedures (e.g., percutaneous drain placement), types of operative repairs, and nonoperative management details.

Disease severity reporting is performed by reviewing clinical, anatomic, and imaging information in the EMR and using the American Association for the Surgery of Trauma (AAST) grading system specifically designed for emergency general surgery diseases.12 The AAST grading scale assigns a value from 1 to 5 based on increasing severity of disease. This value represents a measurement of inflammation and degree of peritonitis present for the specific condition. The AAST grading scale has been validated for the two disease cohorts, acute appendicitis and acute cholecystitis, in which we are employing data capture.1315 The AAST grades were assigned during data abstraction and were not available or assigned during the patient’s hospitalization.

A MACS data definitions manual has been created and is updated annually (https://www.mtqip.org/resources/macs). Most of the data definitions are based upon existing standards in already available national sources (American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP), ACS Trauma Quality Improvement Program, Centers for Disease Control) and regionally (MTQIP, Michigan Surgical Quality Collaborative (MSQC)). Disease-specific data elements were created to capture studies performed, all operative interventions, interventional procedures, disease-specific outcomes, and nonoperative management. This is in addition to commonly found data elements in existing quality improvement platforms. Data validation visits are conducted annually, using a methodology like what has been published for trauma, with feedback provided to participants.16

Reporting

Hardcopy reports are created and distributed to each participant hospital every four months in conjunction with in-person meetings (SDC 4). The information includes a program summary of all patients. There are also disease-specific reports on acute appendicitis, acute gallbladder disease, small bowel obstruction, and exploratory laparotomy. Participant hospital data is compared to the collaborative in table and graphical form. Morbidity is reported as a composite that includes any incidence of a complication or mortality recorded in the index or subsequent readmission records.

Data Analysis

Multivariable generalized linear regression models were constructed for mortality, complications, and all other reported outcomes. For binary outcomes, a logit link function was used, and for continuous outcomes, a normal distribution was used. A stepwise selection process was used, to create a parsimonious multivariable model for each primary outcome while controlling for relevant candidate confounders, like demographics, disease factors, comorbid conditions, and hospital processes. If a model did not converge using the full selected model, a smaller model was tested using basic demographic variables. Most models converged using the full model. However, some outcomes were extremely rare; moreover, there was insufficient power to include many variables. We included AAST grade in the multivariable model(s) for acute appendicitis and acute gallbladder outcomes. Categorical variables being considered for use in modeling had a category of missing/not classed/not graded created to avoid the exclusion of patients in the analysis.

Results are expressed as risk-adjusted rates along with 95% confidence intervals. Risk-adjusted rates were calculated by adding the residual for each site (observed rate minus expected rate) to the overall observed rate. To compare sites to the collaborative, we calculated Z-tests for binary outcomes and t-tests for continuous outcomes. A p-value less than 0.05 was used as the threshold for statistical significance, and all reported p-values were 2-sided. If the p-value was significant, and the center rate was less than the collaborative rate, the center was reported as a low-outlier. If the p-value was significant and the center rate was more than the collaborative rate, the center was reported as a high outlier.

All statistical analyses were performed in Stata 15.0 (StataCorp, College Station, TX) or SAS 9.4 (SAS Institute, Inc., Cary, NC). Institutional Review Board approval was obtained for this study, and it was deemed exempt as it relied on the secondary use of already collected data. The SQUIRE 2.0 guideline was used to ensure proper reporting of methods, results, and discussion for a quality improvement study (SDC 5).17

Results

MACS CQI data collection included a total of 19,956 emergency general surgery patients. Of these, 56.8% were female, 82.8% were white, and the mean (SD) age was 53.3 (20.8) years (Table 1A & 1B). 3,013 (15.1%) patients had one or more readmission events. The prevalence of the top fifteen diagnosis codes and operations performed during index admission are detailed in Table 2. 12.9% of patients were transferred to a collaborative hospital after being seen in a referring hospital ED or being admitted to an outside hospital prior to transfer. Within the collaborative, 15,382 (77%) patients underwent operative intervention during their index admission.

Table 1.

Patient Characteristics

A. Overall
Patient Characteristic Management Cohort
Aggregate Operative Non-Operative
Cases, N 19,956 15,382 4,574
By Disease, N (%)
 Acute Appendicitis 5325 (26.7) 4,605 (29.9) 720 (15.7)
 Acute Gallbladder Disease 8,681 (43.5) 7,322 (47.6) 1,359 (29.7)
 Small Bowel Obstruction 3,856 (19.3) 1,361 (8.9) 2,495 (54.6)
 Exploratory Laparotomy 2,094 (10.5) 2,094 (13.6) 0 (0.0)
Point of Patient Entry, N (%)
 Emergency Department 15,627 (78.3) 12,168 (79.1) 3,459 (75.6)
 Transfer from Outside Hospital ED 2,141 (10.7) 1,500 (9.8) 641 (14.0)
 Transfer from Outside Hospital 438 (2.2) 319 (2.1) 119 (2.6)
 ED Only/Not Admitted 194 (1.0) 0 (0.0) 194 (4.2)
 Home/Direct Admit 1,428 (7.2) 1,294 (8.4) 134 (2.9)
 Other 128 (0.6) 101 (0.7) 27 (0.6)
Payment, N (%)
 Private/Other Government 8,003 (40.1) 6,672 (43.4) 1,331 (29.1)
 Medicaid 2,657 (13.3) 2,189 (14.2) 468 (10.2)
 Medicare 5,842 (29.3) 3,912 (25.4) 1,930 (42.2)
 Uninsured/Self pay 387 (1.9) 338 (2.2) 49 (1.1)
 Missing 3,059 (15.3) 2,263 (14.7) 796 (17.4)
Age, Mean (SD) 53.3 (20.8) 50.9 (20.8) 61.3 (18.6)
Race, N (%)
 White 16,520 (82.8) 12,684 (82.5) 3,836 (83.9)
 Black 1,891 (9.5) 1,440 (9.4) 451 (9.9)
 Other 1,545 (7.7) 1,258 (8.2) 287 (6.3)
Sex, N (%)
 Female 11,336 (56.8) 9,019 (58.6) 2,317 (50.7)
 Male 8,614 (43.2) 6,357 (41.3) 2,257 (49.3)
Height (cm)
 Mean (SD) 169 (10.7) 169 (10.6) 170 (10.8)
 Median (IQR) 168 (162–178) 168 (161–178) 170 (163–178)
Weight (kg)
 Mean (SD) 87 (24.8) 88 (25) 84.9 (26.2)
 Median (IQR) 84 (70–100) 84 (71–101) 81 (67–98)
Body Mass Index
 Mean (SD) 30 (8.3) 31 (8.1) 30 (8.6)
 Median (IQR) 29 (25–35) 30 (25–35) 28 (24–33)
Comorbid Conditions, N (%)
 Ascites 201 (1.2) 121 (0.9) 80 (2.1)
 CHF within 30 days 241 (1.4) 135 (1.0) 106 (2.8)
 COPD 724 (4.3) 463 (3.5) 261 (6.9)
 COVID-19 1,326 (7.8) 967 (7.4) 359 (9.5)
 Current Cancer/Malignancy 1,033 (6.1) 599 (4.6) 434 (11.5)
 Diabetes Mellitus 2,357 (11.8) 1,631 (10.6) 726 (15.9)
 Dialysis within 2 weeks 209 (1.2) 135 (1.0) 74 (2.0)
 Disseminated Cancer 425 (2.5) 227 (1.7) 198 (5.2)
 Hypertension 6,318 (37.4) 4,484 (34.2) 1,834 (48.6)
 Functional Health Status - Dependent 689 (4.1) 410 (3.1) 279 (7.4)
 History of DVT/PE 1,121 (6.6) 733 (5.6) 388 (10.3)
 Pregnancy 81 (0.4) 68 (0.4) 13 (0.3)
 Sepsis 2,977 (17.6) 2,451 (18.7) 526 (13.9)
 Severe Sepsis/Septic Shock 1,385 (8.2) 1,042 (7.9) 343 (9.1)
 Sleep Apnea 3,546 (21.0) 2,530 (19.3) 1,016 (26.9)
 Solid Organ Transplant 111 (0.8) 70 (0.6) 41 (1.2)
 Steroid or Immunosuppressive Rx 1,017 (6.0) 597 (4.6) 420 (11.1)
 Tobacco within 1 year - Cigarette 2,562 (15.2) 2,033 (15.5) 529 (14.0)
 Ventilator dependent within 48 hours 283 (1.7) 220 (1.7) 63 (1.7)

ED, Emergency Department; cm, centimeters; SD, standard deviation; IQR, interquartile range; kg, kilograms; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; DVT, deep vein thrombosis; PE, pulmonary embolism; Rx, prescription medication.

B. By disease
Patient Characteristic Appendicitis Gallbladder Small Bowel Exploratory Laparotomy
Operative Non-Operative Operative Non-Operative Operative Non-Operative
Cases, N 4,605 720 7,322 1,359 1,361 2,495 2,094
Point of Patient Entry, N (%)
 Emergency Department 4,199 (91.2) 572 (79.4) 5,450 (74.4) 861 (63.4) 1,085 (79.7) 2,026 (81.2) 1,434 (68.5)
 Transfer from Outside Hospital ED 151 (3.3) 80 (11.1) 807 (11.0) 256 (18.8) 151 (11.1) 305 (12.2) 391 (18.7)
 Transfer from Outside Hospital 11 (0.2) 7 (1.0) 138 (1.9) 67 (4.9) 45 (3.3) 45 (1.8) 125 (6.0)
 ED Only/Not Admitted 0 (0.0) 44 (6.1) 0 (0.0) 99 (7.3) 0 (0.0) 51 (2.0) 0 (0.0)
 Home/Direct Admit 211 (4.6) 9 (1.3) 874 (11.9) 63 (4.6) 77 (5.7) 62 (2.5) 132 (6.3)
 Other 33 (0.7) 8 (1.1) 53 (0.7) 13 (1.0) 3 (0.2) 6 (0.2) 12 (0.6)
Payment, N (%)
 Private/Other Government 2,648 (57.6) 335 (46.5) 3,098 (42.3) 336 (24.7) 298 (21.9) 660 (26.5) 628 (30.0)
 Medicaid 598 (13.0) 90 (12.5) 1,162 (15.9) 163 (12.0) 141 (10.4) 215 (8.6) 288 (13.8)
 Medicare 447 (9.7) 146 (20.3) 1,729 (23.6) 665 (48.9) 589 (43.3) 1,119 (44.8) 1,147 (54.8)
 Uninsured/Self pay 140 (3.0) 15 (2.1) 152 (2.1) 13 (1.0) 16 (1.2) 21 (0.8) 30 (1.4)
 Missing 768 (16.7) 134 (18.6) 1,178 (16.1) 182 (13.4) 316 (23.2) 480 (19.2) 1 (0.0)
Age, Mean (SD) 40.7 (21.7) 48.9 (18.8) 51.3 (18.7) 64.0 (19.5) 64.4 (16.4) 63.4 (16.4) 62.9 (15.8)
Race, N (%)
 White 3,810 (82.7) 570 (79.2) 6,021 (82.2) 1,148 (84.5) 1,088 (79.9) 2,118 (84.9) 1,765 (84.3)
 Black 326 (7.1) 73 (10.1) 691 (9.4) 130 (9.6) 208 (15.3) 248 (9.9) 215 (10.3)
 Other 469 (10.2) 77 (10.7) 610 (8.3) 81 (6.0) 65 (4.8) 129 (5.2) 114 (5.4)
Sex, N (%)
 Female 2,429 (52.7) 358 (49.7) 4,715 (64.4) 667 (49.1) 764 (56.1) 1,292 (51.8) 1,111 (53.1)
 Male 2,175 (47.2) 362 (50.3) 2,604 (35.6) 692 (50.9) 596 (43.8) 1,203 (48.2) 982 (46.9)
Height (cm)
 Mean (SD) 170.5 (10.5) 170.7 (10.4) 168.3 (10.4) 169.7 (11.0) 168.9 (11.1) 169.1 (10.7) 169.1 (11.1)
 Median (IQR) 170. (163–177) 170 (163–179) 168 (160–175) 170 (163–178) 168 (160–178) 170 (160–178) 168 (160–178)
Weight (kg)
 Mean (SD) 85.1 (22.5) 85.1 (25.6) 91.7 (23.7) 88.1 (27.6) 82.0 (27.2) 83.0 (25.3) 83.3 (25.9)
 Median (IQR) 81.7 (69–97.5) 80.6 (67.7–97) 88.85 (75.3–105) 83.6 (70.2–101) 77.7 (63.5–95) 79.3 (64.9–97) 79.2 (64.9–97.5)
Body Mass Index
 Mean (SD) 29.3 (7.5) 29.1 (8.6) 32.3 (7.8) 30.5 (8.8) 28.7 (9.0) 28.9 (8.3) 29.1 (8.7)
 Median (IQR) 28.1 (24.1–32.8) 27.4 (23.6–32.3) 31.1 (27.0–36.5) 29.1 (24.9–34.1) 26.5 (22.9–32.7) 27.4 (23.1–33.1) 27.7 (23.3–33.1)
Comorbid Condition, N (%)
 Ascites 3 (0.1) 2 (0.3) 12 (0.2) 28 (2.4) 29 (2.8) 50 (2.5) 77 (3.7)
 CHF within 30 days 9 (0.2) 6 (1.0) 45 (0.7) 65 (5.5) 17 (1.6) 35 (1.7) 64 (3.1)
 COPD 48 (1.3) 11 (1.9) 147 (2.4) 114 (9.7) 87 (8.3) 136 (6.7) 181 (8.6)
 COVID-19 286 (7.5) 72 (12.3) 430 (7.0) 126 (10.7) 67 (6.4) 161 (8.0) 184 (8.8)
 Current Cancer/Malignancy 73 (1.9) 34 (5.8) 144 (2.3) 145 (12.3) 94 (9.0) 255 (12.7) 288 (13.8)
 Diabetes Mellitus 238 (5.2) 76 (10.6) 860 (11.7) 273 (20.1) 163 (12.0) 377 (15.1) 370 (17.7)
 Dialysis within 2 weeks 5 (0.1) 3 (0.5) 25 (0.4) 47 (4.0) 14 (1.3) 24 (1.2) 91 (4.3)
 Disseminated Cancer 7 (0.2) 17 (2.9) 26 (0.4) 56 (4.8) 42 (4.0) 125 (6.2) 152 (7.3)
 Hypertension 675 (17.6) 160 (27.4) 2,208 (35.9) 685 (58.2) 523 (50.0) 989 (49.1) 1,078 (51.5)
 Functional Health Status - Dependent 14 (0.4) 19 (3.2) 121 (2.0) 141 (12.0) 58 (5.6) 119 (5.9) 217 (10.4)
 History of DVT/PE 87 (2.3) 24 (4.1) 261 (4.2) 120 (10.2) 115 (11.0) 244 (12.1) 270 (12.9)
 Pregnancy 23 (0.5) 3 (0.4) 43 (0.6) 9 (0.7) 0 (0.0) 1 (0.04) 2 (0.1)
 Sepsis 1,157 (30.1) 230 (39.3) 884 (14.4) 242 (20.6) 48 (4.6) 54 (2.7) 362 (17.3)
 Severe Sepsis/Septic Shock 149 (3.9) 37 (6.3) 276 (4.5) 245 (20.8) 28 (2.7) 61 (3.0) 589 (28.1)
 Sleep Apnea 423 (11.0) 99 (16.9) 1,213 (19.7) 380 (32.3) 268 (25.6) 537 (26.7) 626 (29.9)
 Solid Organ Transplant 10 (0.3) 0 (0.0) 21 (0.4) 11 (1.1) 10 (1.1) 30 (1.7) 29 (1.6)
 Steroid or Immunosuppressive Rx 77 (2.0) 41 (7.0) 189 (3.1) 123 (10.5) 71 (6.8) 256 (12.7) 260 (12.4)
 Tobacco within 1 year - Cigarette 481 (12.5) 90 (15.4) 891 (14.5) 162 (13.8) 202 (19.3) 277 (13.7) 459 (21.9)
 Ventilator dependent within 48 hours 2 (0.1) 4 (0.7) 56 (0.9) 45 (3.8) 5 (0.5) 14 (0.7) 157 (7.5)

ED, Emergency Department; cm, centimeters; SD, standard deviation; IQR, interquartile range; kg, kilograms; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; DVT, deep vein thrombosis; PE, pulmonary embolism; Rx, prescription medication.

Table 2.

A. Primary ICD-10-CM diagnosis.
Code Description N %
K56.609 Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction 1,561 7.8
K35.80 Unspecified acute appendicitis 1,552 7.8
K35.30 Acute appendicitis with localized peritonitis, without perforation or gangrene 1,482 7.4
K80.00 Calculus of gallbladder with acute cholecystitis without obstruction 1,458 7.3
K81.0 Acute cholecystitis 1,136 5.7
K80.12 Calculus of gallbladder with acute and chronic cholecystitis without obstruction 921 4.6
K85.10 Biliary acute pancreatitis without necrosis or infection 829 4.2
K80.10 Calculus of gallbladder with chronic cholecystitis without obstruction 812 4.1
K35.32 Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess 717 3.6
K56.50 Intestinal adhesions [bands], unspecified as to partial versus complete obstruction 573 2.9
K35.890
K35.891
Other acute appendicitis without perforation or gangrene
Other acute appendicitis without perforation, with gangrene
524 2.6
K56.600
K56.601
Partial intestinal obstruction, unspecified as to cause
Complete intestinal obstruction, unspecified as to cause
500 2.5
K35.33 Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess 496 2.5
K80.50 Calculus of bile duct without cholangitis or cholecystitis without obstruction 388 1.9
K80.20 Calculus of gallbladder without cholecystitis without obstruction 268 1.3
Other All other diagnoses 6,739 33.8
B. Current Procedural Terminology (CPT) codes for primary operation performed.
Code Description N %
47562 Laparoscopic cholecystectomy 5,923 38.5
44970 Laparoscopic appendectomy 4,279 27.8
47563 Laparoscopic cholecystectomy with IOC 903 5.9
44120 Resection of small intestine 608 4.0
44005 Freeing of bowel adhesion 434 2.8
47600 Open cholecystectomy 312 2.0
49000 Exploration of abdomen 229 1.5
44140 Partial colectomy with anastomosis 209 1.4
44143 Partial colectomy with colostomy 198 1.3
43840 Gastrorrhaphy, Graham patch 188 1.2
44950 Open appendectomy 168 1.1
44160 Partial colectomy with terminal ileum 131 0.9
49561 Repair ventral/incisional hernia 128 0.8
49320 Laparoscopy, diagnostic 117 0.8
44050 Incision procedure on intestines 103 0.7
Other All other procedures 1,452 9.4

ICD-10-CM Clinical Modification of the 10th revision of the International Statistical Classification of Diseases and Related Health Problems.

IOC, Intra-operative cholangiogram.

The model constructed for mortality had a c-index of 0.96, and similar risk-adjustment models were constructed for all the other investigated outcomes (SDC 6: Models for mortality, morbidity, ED visit, and readmission). The c-index for the final models ranged from 0.57 to 0.96, and there were 69 models constructed. Risk-adjusted mortality rates, morbidity (mortality and/or complication), ED visits, readmissions, and select individual complications are shown in Table 3 and SDC 7. Hospital and intensive care unit length of stay in hours are also shown. Adjusted mortality varied from 2.3% to 4.2% between the 10 hospitals for the overall cohort of patients (Figure 2). There was one statistically significant low-outlier and one high-outlier hospital for mortality. Differences between hospitals were also found in the composite of mortality or complications and readmissions. However, there were no significant differences in hospital length of stay between the hospitals in the collaborative (Mean = 112.2 hours).

Table 3.

Risk-adjusted outcomes

Outcome Aggregate Acute Appendicitis Acute Gallbladder Disease Small Bowel Obstruction Exploratory Laparotomy
Cases
 Overall, N 19,956 5,325 8,681 3,856 2,094
 With operation, % (N) 77.1 (15,382) 86.5 (4,605) 84.3 (7,322) 35.3 (1,361) 100 (2,094)
 Without operation, % (N) 22.9 (4,574) 13.5 (720) 15.7 (1,359) 64.7 (2,495) --
Mortality*, % (95% CI)
 Overall 3.5 (3.2–3.7) 0.3 (0.1–0.4) 2.2 (1.9–2.5) 4.3 (3.7–4.9) 15.4 (13.9–16.9)
 With operation 2.7 (2.5–3.0) 0.2 (0.1–0.4) 0.3 (0.2–0.5) 4.5 (3.5–5.5) --
 Without operation 4.7 (4.0–5.3) 0.6 (0.0–1.2) 7.8 (6.3–9.4) 4.2 (3.4–4.9) --
Mortality or Complication*#, % (95% CI)
 Overall 27.6 (27.0–28.3) 19.6 (18.5–20.7) 26.7 (25.7–27.6) 34.3 (32.9–35.8) 62.3 (60.3–64.3)
 With operation 27.2 (26.5–27.9) 19.2 (18.1–20.3) 22.8 (21.9–23.8) 51.3 (48.8–53.7) --
 Without operation 29.3 (27.9–30.8) 23.5 (19.9–27.1) 35.2 (32.4–38.1) 28.4 (26.6–30.2) --
ED Visit, % (95% CI)
 Overall 8.4 (8.0–8.7) 8.2 (7.5–9.0) 7.8 (7.2–8.3) 8.5 (7.7–9.4) 11.6 (10.3–12.9)
 With operation 8.3 (7.9–8.7) 8.1 (7.3–8.9) 7.3 (6.7–7.9) 9.7 (8.3–11.2) --
 Without operation 8.6 (7.7–9.5) 9.7 (7.2–12.2) 10.7 (8.9–12.5) 7.8 (6.7–8.8) --
Readmission, % (95% CI)
 Overall 15.1 (14.6–15.6) 15.5 (14.5–16.5) 12.7 (12.0–13.4) 26.0 (24.7–27.4) 27.2 (25.4–29.0)
 With operation 14.1 (13.6–14.7) 14.5 (13.5–15.5) 11.5 (10.8–12.2) 29.2 (26.9–31.4) --
 Without operation 19.1 (17.8–20.3) 15.5 (12.4–18.6) 21.2 (18.8–23.6) 23.9 (22.2–25.6) --
Incisional SSI, % (95% CI) 1.4 (1.2–1.6) 0.7 (0.5–1.0) 0.6 (0.5–0.8) 4.1 (3.1–5.0) 4.4 (3.5–5.2)
Organ Space SSI, % (95% CI) 2.9 (2.6–3.1) 2.2 (1.8–2.6) 0.9 (0.7–1.1) 2.8 (2.0–3.6) 11.8 (10.5–13.2)
Hospital LOS, hrs (95% CI) 112 (109–115) 53.0 (50.0–56.2) 109 (104–114) 60.5 (54.9–66.1) 302 (289–315)
ICU LOS, hrs (95% CI) 208 (204–213) -- -- -- 187 (173–200)

CI, confidence interval; ED, Emergency Department; SSI, surgical site infection; LOS, length of stay; ICU, intensive care unit.

*

Mortality represents inpatient death.

#

Complications included any incidence of the following: Incisional SSI, Organ space SSI, Anastomotic leak, Wound disruption, Enterocutaneous fistula, ileus, C. difficile colitis, Venous thromboembolism, new COVID infection, Pancreatitis, Pneumonia, Cardiac arrest, Sepsis or severe sepsis, Post-discharge ED visit, or Readmission.

Intensive care unit length of stay was calculated only for patients who were admitted to an ICU.

Figure 2.

Figure 2.

Risk-adjusted outcome rates by hospital with 95% confidence intervals. A. Morbidity (mortality and/or complication), B. Mortality (inpatient), C. Readmissions, D. Hospital length of stay. Black bar = low-outlier performance, Gray bar = average performance, Red bar = high-outlier performance, Dashed line = collaborative mean.

Participant hospitals varied in their percent operative versus nonoperative management of appendicitis, acute gallbladder disease, and small bowel obstruction during index admission (Figure 3). The type of operation performed also varied with open, laparoscopic, laparoscopic converted to open, and robotic approaches all being utilized among the participant hospitals. The use of a Gastrografin (diatrizoate meglumine/diatrizoate sodium) challenge in patients with adhesive in origin small bowel obstruction ranged from 10.7% to 61.4% of patients. In patients who underwent initial nonoperative management of acute cholecystitis gallbladder disease, 51.5% had a cholecystostomy tube placed. The cholecystostomy tube placement rate ranged from 23.5% to 62.1% across hospitals.

Figure 3.

Figure 3.

Process measures by hospital. A. Operative intervention for acute appendicitis, acute gallbladder disease, and small bowel obstruction. B. Type of operative approach for adhesive small bowel obstruction excluding malignancy, Crohn’s, hernia, and vascular insufficiency causes. C. Rate of cholecystostomy tube placement in nonoperative acute cholecystitis gallbladder disease patients. D. Rate of use of Gastrografin challenge test in patients with small bowel obstruction. Dashed line = collaborative mean.

Discussion

In this study, we describe the construct of a CQI for emergency general surgery and document the initial results for outcomes and processes. Unique features of our CQI infrastructure include the limitation of data collection to four emergency general surgery conditions, collapsing multiple patient admissions to define longitudinal results over time, and data collection on operative and nonoperatively managed patients. Fifteen operative procedures described the specific intervention performed for >90% of the patients who underwent an operation for the four emergency general surgery conditions being investigated. There was significant variation in processes and outcomes between participant hospitals.

There is an increasing body of evidence demonstrating that the practice of emergency general surgery is not optimized, and that there exists excess mortality from these operations.18,19 Factors that may contribute to adverse outcomes include, delays in operative intervention and/or transfer, experience of the treating surgeon, operative volume, and care discontinuity.2027 In September 2022, the ACS and AAST launched the new multidisciplinary Emergency General Surgery quality and verification program (EGS-VP), which sets 42 standards designated in a resource document.28,29 The program also leverages the ACS NSQIP registry (EGS Targeted Module) to capture data on both operative and nonoperative emergency general surgery cases.30 Additional proposals to address emergency general surgery quality improvement have been published with suggestions for a data registry, standardization of pathways, structure of quality improvement processes, and defining of high-yield topics.8,31

Within the state of Michigan, Blue Cross Blue Shield of Michigan/Blue Care Network has sponsored a growing portfolio of procedural-based CQIs since 1997 with the launch of an initial program centered on percutaneous coronary interventions.32,33 The Michigan Trauma Quality Improvement Program began in 2008 and focuses on trauma care, one of the key clinical domains of acute care surgery.34,35 A unique aspect of MTQIP and trauma registries is the collection of data on both operative and nonoperative patients. Collecting data on both operative and nonoperative patients is necessary to paint a complete picture of emergency general surgery care.30 Data collection must also account for patients on other inpatient services seen by emergency general surgery providers as a consult and those residing on the Acute Care Surgical service.

The MACS collaborative meetings are held three times per year and are in person when possible. Surgeon champions and data abstractors from each participant hospital are required to attend. Data are unmasked at meetings to facilitate discussion and are protected by using nondisclosure agreements. Participants are encouraged to ask questions and share experiences to allow for a learning health system environment.36 Hardcopy reports are distributed in advance and form the basis for the presentation of data at collaborative meetings. Like MTQIP, a hospital report card is being constructed and will include performance and participation metrics.35 Deep dives into the data surrounding outcomes and processes are encouraged, and participant hospitals have presented their results of data reviews at recent CQI meetings.

Patient readmission to the hospital is a challenging data capture and analytic circumstance in emergency general surgery.37 We have elected to capture readmission events by performing complete data abstraction for every patient’s admission to the hospital. Emergency department visits not resulting in hospital admission, and 30-day outcome data available from non-readmission encounters are entered into the prior admission record created for the patient. Index admission records are defined in the analytic algorithm, and outcomes are rolled up by collapsing data records on the index and subsequent readmission data entries for each patient to create an episode of care.

How much data to associate with an episode of care remains an open question. In the 6 months after initial admission, up to 20% of emergency general surgery patients experience a readmission, and 1 in 9 patients require an additional surgical procedure.38 The readmission rate in our study was 15.1% for the aggregate cohort, and we found a substantial number of patients that required additional operations or interventions. Recent evidence proposes that unmodifiable patient and disease-related factors may drive hospital readmissions in emergency general surgery.39 Hence, it was suggested that readmissions might be reduced by implementing postdischarge surveillance systems leveraging telehealth and in-person outpatient care provided by surgeons, primary care providers, and appropriate specialists. These postdischarge interventions will require data collection and analytic mechanisms for episodes of care that can document and collapse information over many months to years. Care and data collection discontinuity also results from patients being readmitted to a hospital other than where their index care was performed.40

There are also nuances of specific outcomes, nonoperative management, and duration of an episode that must be considered within each disease cohort. For example, acute appendicitis patients who undergo nonoperative management need a longer follow-up than the standard 30–90 days to capture the prevalence of disease reoccurrence.4143 Acute gallbladder disease requires capturing disease-specific complications such as cystic duct stump leak and common bile duct injury. In addition, capture of nonoperative interventions like endoscopic retrograde cholangiopancreatography, cystic duct stenting, and cholecystostomy tube placement allows for a complete picture of disease management. Patients undergoing emergent exploratory laparotomy can be at substantial risk for morbidity and mortality due to the degree of physiologic derangement present. To measure the pre-operative severity of illness, we collect information that allows calculation of the Royal College of Physicians-developed National Early Warning Score 2, utilized in the United Kingdom by the National Health Service.44

In the future, we intend to incorporate patient-reported outcomes into the MACS program using telephone and electronic-based surveys. Amendments to our participation agreements allow for merging data from MACS with data from the corresponding Blue Cross Blue Shield of Michigan/Blue Care Network-sponsored collaboratives focused on anesthesiology (Anesthesiology Performance Improvement and Reporting Exchange (ASPIRE)) and surgery (MSQC). These same amendments allow for sharing data, reports, and findings with ASPIRE and MSQC, fostering wide dissemination of quality improvement efforts in emergency general surgery to the appropriate collaborative stakeholders.

Extensive collection of processes of care has occurred in addition to investigating patient outcomes. Differences have been found in the use of a robotic surgical approach; which patients to consider for nonoperative treatment of acute appendicitis, acute cholecystitis, and small bowel obstruction; use of laparoscopy in operative treatment of SBO; cholecystostomy tube utilization in acute cholecystitis; and Gastrografin challenge in SBO. These differences have stimulated extensive discussions at CQI meetings. Based on these discussions, we have initiated efforts to create optimal care pathways and ascertain appropriate eligibility for the use of these processes of care, which may influence patient outcomes.

There are several limitations to our study and the work done so far in creating the MACS CQI for EGS that merit discussion. Risk-adjustment models in the literature were considered for use, but none were deemed practical to utilize in MACS risk-adjusted reporting. This was due to not having fully published variables with coefficients, lack of modeling beyond a few selected outcomes, and published models such as POTTER or ACS NSQIP were often only available for use in a single patient calculator format.4547 However, the variables used in these published models did guide us in what data to consider collecting and what co-variates to utilize when constructing an outcome model. Complete capture of patients to be included in data abstraction was reliant on manual review of patient records in our study. It must be acknowledged that the use of manual methods and in some cases individualized institution specific methods to screen for potential patients could have induced bias in the selection of patients for data abstraction. Development and utilization of automated EMR screening mechanisms in the future could potentially increase standardization and optimize patient selection thereby minimizing differences in patient inclusion across hospitals. Within the emergency laparotomy cohort, we did not collect information on patients who were consulted on and declined operative intervention or were not offered an operation. Consideration of developing a definition for this category that would capture patients for whom emergency laparotomy was a viable treatment option but not offered/performed might reduce bias in what the true denominator is for this cohort. Delineation of what cohorts of patients to collect data on, what data to collect, the robustness of risk adjustment, and how to report the data in a meaningful way are all efforts that are in their infancy and await additional investigation.

Summary

We have described the construct and initial experience of a CQI for emergency general surgery. The MACS CQI aims to use a comparative effectiveness model to enhance quality reporting and promote meaningful quality improvement for emergency general surgery patients in Michigan. The support of a third-party payer providing a safe space for collaboration has been essential to the successful launch and growth of this emergency general surgery initiative.

Supplementary Material

Supplemental Data File 1

SDC 1. MACS participant hospital eligibility and expectations

Supplemental Data File 2

SDC2. MACS patient selection inclusion and exclusion criteria

Supplemental Data File 3

SDC3. Guidance for placement of small bowel obstruction cases

Supplemental Data File 4

SDC4. MACS report examples

Supplemental Data File 5

SDC5. SQUIRE 2.0 Checklist

Supplemental Data File 6

SDC6. Risk adjustment model for mortality

Supplemental Data File 7

SDC7. Rates of individual complications

SDC8. JTAC Author Disclosure Forms

Acknowledgements

We recognize the MACS clinical reviewers, trauma program managers, and surgical champions at the member hospitals for their dedication to collection of the data and participation in MACS.

Funding/Support:

This study was supported by a Blue Cross Blue Shield of Michigan and Blue Care Network Collaborative Quality Initiatives grant to Mark R. Hemmila to administer the Michigan Trauma Quality Improvement Program. John W. Scott was supported by grants K08-HS028672 and R01-HS027788 from the Agency for Healthcare Research and Quality.

Role of the Funder/Sponsor:

The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Footnotes

Conflicts of Interest Disclosure: All Journal of Trauma and Acute Care Surgery disclosure forms have been supplied and are provided as supplemental digital content (SDC 8).

Presented at: This paper was an oral presentation at the American Association for the Surgery of Trauma meeting, Anaheim, CA, on September 22, 2023. It has not been submitted for publication elsewhere.

Reprints will not be available from the authors.

References

  • 1.Esposito TJ, Rotondo M, Barie PS, Reilly P, Pasquale MD. Making the case for a paradigm shift in trauma surgery. J Am Coll Surg. 2006;202:655–667. [DOI] [PubMed] [Google Scholar]
  • 2.Moore EE, Maier RV, Hoyt DB, Jurkovich GJ, Trunkey DD. Acute care surgery: Eraritjaritjaka. J Am Coll Surg. 2006;202:698–701. [DOI] [PubMed] [Google Scholar]
  • 3.Napolitano LM, Fulda GJ, Davis KA, Ashley DW, Friese R, Van Way CW 3rd, et al. Challenging issues in surgical critical care, trauma, and acute care surgery: a report from the Critical Care Committee of the American Association for the Surgery of Trauma. J Trauma. 2010;69:1619–1633. [DOI] [PubMed] [Google Scholar]
  • 4.Knowlton LM, Minei J, Tennakoon L, Davis KA, Doucet J, Bernard A, et al. The economic footprint of acute care surgery in the United States: Implications for systems development. J Trauma Acute Care Surg. 2019;86:609–616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gale SC, Shafi S, Dombrovskiy VY, Arumugam D, Crystal JS. The public health burden of emergency general surgery in the United States: a 10-year analysis of the Nationwide Inpatient Sample - 2001 to 2010. J Trauma Acute Care Surg. 2014;77:202–208. [DOI] [PubMed] [Google Scholar]
  • 6.Havens JM, Peetz AB, Do WS, Cooper Z, Kelly E, Askari R, et al. The excess morbidity and mortality of emergency general surgery. J Trauma Acute Care Surg. 2015;78:306–311. [DOI] [PubMed] [Google Scholar]
  • 7.Scott JW, Tsai TC, Neiman PU, Jurkovich GJ, Utter GH, Haider AH, et al. Lower emergency general surgery (EGS) mortality among hospitals with higher-quality trauma care. J Trauma Acute Care Surg. 2018;84:433–440. [DOI] [PubMed] [Google Scholar]
  • 8.Havens JM, Neiman PU, Campbell BL, Croce MA, Spain DA, Napolitano LM. The Future of Emergency General Surgery. Ann Surg. 2019;270:221–222. [DOI] [PubMed] [Google Scholar]
  • 9.Hemmila MR, Cain-Nielsen AH, Jakubus JL, Mikhail JN, Dimick JB. Association of hospital participation in a regional trauma quality improvement collaborative with patient outcomes. JAMA Surg. 2018;153:747–756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tominaga GT, Staudenmayer KL, Shafi S, Schuster KM, Savage SA, Ross S, et al. ; American Association for the Surgery of Trauma Committee on Patient Assessment. The American Association for the Surgery of Trauma grading scale for 16 emergency general surgery conditions: Disease-specific criteria characterizing anatomic severity grading. J Trauma Acute Care Surg. 2016;81:593–602. [DOI] [PubMed] [Google Scholar]
  • 11.Scott JW, Olufajo OA, Brat GA, Rose JA, Zogg CK, Haider AH, et al. Use of National Burden to Define Operative Emergency General Surgery. JAMA Surg. 2016;151:e160480. [DOI] [PubMed] [Google Scholar]
  • 12.Data Dictionaries for AAST Grading System for EGS Conditions. American Association for the Surgery of Trauma Web site. https://www.aast.org/resources-detail/egs. Accessed July 12, 2023.
  • 13.Mouch CA, Cain-Nielsen AH, Hoppe BL, Giudici MP, Montgomery JR, Scott JW, et al. Validation of the AAST grading system for acute appendicitis severity. J Trauma Acute Care Surg. 2020;88:839–846. [DOI] [PubMed] [Google Scholar]
  • 14.Vera K, Pei KY, Schuster KM, Davis KA. Validation of a new American Association for the Surgery of Trauma (AAST) anatomic severity grading system for acute cholecystitis. J Trauma Acute Care Surg. 2018;84:650–654. [DOI] [PubMed] [Google Scholar]
  • 15.Schuster KM, O’Connor R, Cripps M, Kuhlenschmidt K, Taveras L, Kaafarani HM, et al. Multicenter validation of the American Association for the Surgery of Trauma grading scale for acute cholecystitis. J Trauma Acute Care Surg. 2021;90:87–96. [DOI] [PubMed] [Google Scholar]
  • 16.Jakubus JL, Di Pasquo S, Mikhail JN, Cain-Nielsen AH, Jenkins PC, Hemmila MR. Pull back the curtain: external data validation is an essential element of quality improvement benchmark reporting. J Trauma Acute Care Surg. 2020;89:199–207. [DOI] [PubMed] [Google Scholar]
  • 17.Ogrinc G, Davies L, Goodman D, Bataldan P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Quality & Safety. 2016;25:986–992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hashmi ZG, Jarmin MP, Havens JM, Scott JW, Goralnick E, Cooper Z, et al. Quantifying lives lost due to variability in emergency general surgery outcomes: Why we need a national emergency general surgery quality improvement program. J Trauma Acute Care Surg. 2021;90:685–693. [DOI] [PubMed] [Google Scholar]
  • 19.DeWane MP, Sukumar N, Stolar MJ, Gill TM, Maung AA, Schuster KM, et al. Top-tier emergency general surgery hospitals: Good at one operation, good at them all. J Trauma Acute Care Surg. 2019;87:289–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Becher RD, DeWane MP, Sukumar N, Stolar MJ, Gill TM, Maung AA, et al. Evaluating mortality outlier hospitals to improve the quality of care in emergency general surgery. J Trauma Acute Care Surg. 2019;87:297–306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.de Mestral C, Rotstein OD, Laupacis A, Hoch JS, Zagorski B, Alali AS, et al. Comparative operative outcomes of early and delayed cholecystectomy for acute cholecystitis: a population-based propensity score analysis. Ann Surg. 2014;259:10–15. [DOI] [PubMed] [Google Scholar]
  • 22.Coimbra R, Barrientos R, Allison-Aipa T, Zakhary B, Firek M. The unequal impact of interhospital transfers on emergency general surgery patients: Procedure risk and time to surgery matter. J Trauma Acute Care Surg. 2022;92:296–304. [DOI] [PubMed] [Google Scholar]
  • 23.Castillo-Angeles M, Uribe-Leitz T, Jarman M, Jin G, Feeney T, Salim A, et al. Transferred Emergency General Surgery Patients Are at Increased Risk of Death: A NSQIP Propensity Score Matched Analysis. J Am Coll Surg. 2019;228:871–877. [DOI] [PubMed] [Google Scholar]
  • 24.Schuster KM, Hazelton JP, Rattigan D, Perez JM, Bhattacharya B. Association of Acute Care Surgeon Experience With Emergency Surgery Patient Outcomes and Mortality. JAMA Surg. 2021;156:472–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Udyavar R, Cornwell EE, Havens JM, Hashmi ZG, Scott JW, Sturgeon D, et al. Surgeon-driven variability in emergency general surgery outcomes: Does it matter who is on call? Surgery. 2018;164:1109–1116. [DOI] [PubMed] [Google Scholar]
  • 26.Becher RD, DeWane MP, Sukumar N, Stolar MJ, Gill TM, Maung AA, et al. Hospital Volume and Operative Mortality for General Surgery Operations Performed Emergently in Adults. Ann Surg. 2020;272:288–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Havens JM, Castillo-Angeles M, Jarman MP, Sturgeon D, Salim A, Cooper Z. Care Discontinuity in Emergency General Surgery: Does Hospital Quality Matter? J Am Coll Surg. 2020;230:863–871. [DOI] [PubMed] [Google Scholar]
  • 28.Coimbra R Another milestone reached: Emergency general surgery verification program. J Trauma Acute Care Surg. 2022;93:425–426. [DOI] [PubMed] [Google Scholar]
  • 29.Emergency General Surgery Verification Program: Program Standards. American College of Surgeons Web site. https://www.facs.org/quality-programs/accreditation-and-verification/emergency-general-surgery/standards/. Accessed July 21, 2023.
  • 30.Wandling MW, Ko CY, Bankey PE, Cribari C, Cryer HG, Diaz JJ, et al. Expanding the scope of quality measurement in surgery to include nonoperative care: Results from the American College of Surgeons National Surgical Quality Improvement Program emergency general surgery pilot. J Trauma Acute Care Surg. 2017;83:837–845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ross SW, Reinke CE, Ingraham AM, Holena DN, Havens JM, Hemmila MR, et al. Emergency general surgery quality improvement: A review of recommended structure and key issues. J Am Coll Surg. 2022;234:214–225. [DOI] [PubMed] [Google Scholar]
  • 32.Moscucci M, Share D, Kline-Rogers E, O’Donnell M, Maxwell-Eward A, Meengs WL, et al. ; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Interv Cardiol. 2002;15:381–386. [DOI] [PubMed] [Google Scholar]
  • 33.Birkmeyer NJ, Share D, Campbell DA Jr, Prager RL, Moscucci M, Birkmeyer JD. Partnering with payers to improve surgical quality: the Michigan plan. Surgery. 2005;138:815–820. [DOI] [PubMed] [Google Scholar]
  • 34.Hemmila MR, Cain-Nielsen AH, Wahl WL, Vander Kolk WE, Jakubus JL, Mikhail JN, et al. Regional collaborative quality improvement for trauma reduces complications and costs. J Trauma Acute Care Surg. 2015;78:78–87. [DOI] [PubMed] [Google Scholar]
  • 35.Hemmila MR, Jakubus JL. Trauma quality improvement. Crit Care Clinics. 2017;33:193–212. [DOI] [PubMed] [Google Scholar]
  • 36.Krapohl GL, Hemmila MR, Hendren S, Bishop K, Rogers R, Rocker C, et al. Building, scaling and sustaining a learning health system for surgical quality improvement: A toolkit. Learn Health Sys. 2020;4:e10215. 10.1002/lrh2.10215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Havens JM, Olufajo OA, Cooper ZR, Haider AH, Shah AA, Salim A. Defining Rates and Risk Factors for Readmissions Following Emergency General Surgery. JAMA Surg. 2016;151:330–336. [DOI] [PubMed] [Google Scholar]
  • 38.Lunardi N, Mehta A, Ezzeddine H, Canner JK, Hamidi M, Jehan F, et al. Recurring emergency general surgery: Characterizing a vulnerable population. J Trauma Acute Care Surg. 2019;86:464–470. [DOI] [PubMed] [Google Scholar]
  • 39.Coimbra R, Allison-Aipa T, Zachary B, Firek M, Edwards S. A comprehensive analysis of 30-day readmissions after emergency general surgery procedures: Are risk factors modifiable? J Trauma Acute Care Surg. 2023;94:61–67. [DOI] [PubMed] [Google Scholar]
  • 40.Havens JM, Olufajo OA, Tsai TC, Jiang W, Columbus AB, Nitzschke SL, et al. Hospital factors associated with care discontinuity following emergency general surgery. JAMA Surg. 2017;152:242–249. [DOI] [PubMed] [Google Scholar]
  • 41.Salminen P, Tuominen R, Paajanen H, Rautio T, Nordstrom P, Aarnio M, et al. Five-year follow-up of antibiotic therapy for uncomplicated acute appendicitis in the APPAC randomized clinical trial. JAMA. 2018;320:1259–1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Flum DR, Davidson GH, Monsell SE, Shapiro NI, Odom SR, Sanchez SE, et al. ; CODA Collaborative. A randomized trial comparing antibiotics with appendectomy for appendicitis. N Engl J Med. 2020;383:1907–1919. [DOI] [PubMed] [Google Scholar]
  • 43.Davidson GH, Flum DR, Monsell SE, Kao LS, Voldal EC, Heagerty PJ, et al. ; CODA Collaborative. Antibiotics versus appendectomy for acute appendicitis - longer - term outcomes. N Engl J Med. 2021;385:2395–2397. [DOI] [PubMed] [Google Scholar]
  • 44.National Early Warning Score (NEWS) 2. Royal College of Physicians Web site. https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2. Accessed July 12, 2023.
  • 45.Sangji NF, Bohnen JD, Ramly EP, Yeh DD, King DR, DeMoya M, et al. Derivation and validation of a novel emergency surgery acuity score (ESAS). J Trauma Acute Care Surg. 2016;81:213–220. [DOI] [PubMed] [Google Scholar]
  • 46.El Hechi M, Maurer LR, Levine J, Zhuo D, El Moheb M, Velmahos GC, et al. Validation of the artificial intelligence-based predictive optimal trees in emergency surgery risk (POTTER) calculator in emergency general surgery and emergency laparotomy patients. J Am Coll Surg. 2021;232:912–919. [DOI] [PubMed] [Google Scholar]
  • 47.Eugene N, Kuryba A, Martin P, Oliver CM, Berry M, Moppett IK, et al. Development and validation of a prognostic model for death 30 days after adult emergency laparotomy. Anaesthesia. 2023;78:1262–1271. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data File 1

SDC 1. MACS participant hospital eligibility and expectations

Supplemental Data File 2

SDC2. MACS patient selection inclusion and exclusion criteria

Supplemental Data File 3

SDC3. Guidance for placement of small bowel obstruction cases

Supplemental Data File 4

SDC4. MACS report examples

Supplemental Data File 5

SDC5. SQUIRE 2.0 Checklist

Supplemental Data File 6

SDC6. Risk adjustment model for mortality

Supplemental Data File 7

SDC7. Rates of individual complications

SDC8. JTAC Author Disclosure Forms

RESOURCES